TY - JOUR
T1 - Improvement in strain concordance between two major vendors after the strain standardization initiative
AU - Yang, Hong
AU - Marwick, Thomas H.
AU - Fukuda, Nobuaki
AU - Oe, Hiroki
AU - Saito, Makoto
AU - Thomas, James D.
AU - Negishi, Kazuaki
N1 - Funding Information:
The following authors reported no actual or potential conflicts of interest in relation to this document: Nobuaki Fukuda, MD, Hiroki Oe, MD, PhD, Makoto Saito, MD, PhD, and James D. Thomas, MD, PhD. The following authors reported relationships with one or more commercial interests: Hong Yang, BMed, is supported by a Health Professional Scholarship from the National Heart Foundation of Australia ( 100307 ); Thomas H. Marwick, MBBS, PhD, MPH, has received research grants from GE Medical Systems and Siemens; and Kazuaki Negishi, MD, PhD, is supported by an award from the Select Foundation.
Publisher Copyright:
© 2015 American Society of Echocardiography.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Background Disagreement of strain measurements among different vendors has provided an obstacle to the clinical use of strain. A joint standardization task force between professional societies and industry was initiated to reduce intervendor variability of strain. Although feedback from this process has been used in software upgrades, little is known about the effects of efforts to improve conformity. The aim of this study was to assess whether intervendor agreement for global longitudinal strain (GLS) has improved after standardization initiatives. Methods Eighty-two subjects (mean age, 52 ± 21 years; 55% men) prospectively underwent two sequential examinations using two most common ultrasound systems (Vivid E9 and iE33). GLS was calculated using proprietary software (EchoPAC-PC BT12 [E12] and BT13 [E13] vs QLAB version 8.0 [Q8], QLAB version 9.0 [Q9], and QLAB version 10.0 [Q10]). Agreements in GLS were evaluated with Bland-Altman plots. Coefficients of variation (CVs) were compared using the Friedman test and compared with CVs of left ventricular volumes and ejection fraction (LVEF). Results Median GLS using E12 was -19.2% (interquartile range [IQR], -15.2% to -23.2%), compared with -19.3% (IQR, -14.9% to -23.7%) for E13, -15.7% (IQR, -11.4% to -20%) for Q8, -19% (IQR, -15.7% to -22.3%) for Q9, and -18.7% (IQR, -15.7% to -21.7%) for Q10. The CVs of prestandardization GLS (12 ± 8% [E12/Q8] and 14 ± 8 [E13/Q8]) were significantly larger than that of LVEF (5 ± 5) (P <.001). Since standardization, the CVs of GLS have shown improvement (6 ± 4 [E12/Q9], 7 ± 4 [E12/Q10], 6 ± 4 [E13/Q9], and 7 ± 4 [E13/Q10]) and are similar to those of LVEF. Conclusions Subsequent to the joint standardization task force, there has been improvement in between-vendor concordance in GLS between two leading ultrasound manufactures, the variability of which is now analogous to that of LVEF. The removal of concerns about measurement variability should allow wider use of GLS.
AB - Background Disagreement of strain measurements among different vendors has provided an obstacle to the clinical use of strain. A joint standardization task force between professional societies and industry was initiated to reduce intervendor variability of strain. Although feedback from this process has been used in software upgrades, little is known about the effects of efforts to improve conformity. The aim of this study was to assess whether intervendor agreement for global longitudinal strain (GLS) has improved after standardization initiatives. Methods Eighty-two subjects (mean age, 52 ± 21 years; 55% men) prospectively underwent two sequential examinations using two most common ultrasound systems (Vivid E9 and iE33). GLS was calculated using proprietary software (EchoPAC-PC BT12 [E12] and BT13 [E13] vs QLAB version 8.0 [Q8], QLAB version 9.0 [Q9], and QLAB version 10.0 [Q10]). Agreements in GLS were evaluated with Bland-Altman plots. Coefficients of variation (CVs) were compared using the Friedman test and compared with CVs of left ventricular volumes and ejection fraction (LVEF). Results Median GLS using E12 was -19.2% (interquartile range [IQR], -15.2% to -23.2%), compared with -19.3% (IQR, -14.9% to -23.7%) for E13, -15.7% (IQR, -11.4% to -20%) for Q8, -19% (IQR, -15.7% to -22.3%) for Q9, and -18.7% (IQR, -15.7% to -21.7%) for Q10. The CVs of prestandardization GLS (12 ± 8% [E12/Q8] and 14 ± 8 [E13/Q8]) were significantly larger than that of LVEF (5 ± 5) (P <.001). Since standardization, the CVs of GLS have shown improvement (6 ± 4 [E12/Q9], 7 ± 4 [E12/Q10], 6 ± 4 [E13/Q9], and 7 ± 4 [E13/Q10]) and are similar to those of LVEF. Conclusions Subsequent to the joint standardization task force, there has been improvement in between-vendor concordance in GLS between two leading ultrasound manufactures, the variability of which is now analogous to that of LVEF. The removal of concerns about measurement variability should allow wider use of GLS.
KW - Concordance
KW - EACVI-ASE strain standardization
KW - Ejection fraction
KW - Strain
KW - Vendor difference
UR - http://www.scopus.com/inward/record.url?scp=84930089180&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930089180&partnerID=8YFLogxK
U2 - 10.1016/j.echo.2014.12.009
DO - 10.1016/j.echo.2014.12.009
M3 - Article
C2 - 25636366
AN - SCOPUS:84930089180
SN - 0894-7317
VL - 28
SP - 642-648.e7
JO - Journal of the American Society of Echocardiography
JF - Journal of the American Society of Echocardiography
IS - 6
ER -